InspireMD (NSPR) Net Cash Flow (2010 - 2025)

InspireMD's Net Cash Flow history runs 16 years deep, the most recent figure standing at -$54.5 million for Q4 2025.

• On a quarterly basis, Net Cash Flow fell 1883.31% year-over-year to -$54.5 million in Q4 2025; TTM through Dec 2025 was -$10.1 million, a 16.98% decrease from a year earlier, with the FY2025 full-year figure at -$10.1 million, down 209.42% from the prior year.
• Net Cash Flow eased to -$54.5 million in Q4 2025 per NSPR's latest filing, from $51.8 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $51.8 million in Q3 2025 and bottomed at -$54.5 million in Q4 2025.
• The 5-year median for Net Cash Flow is -$1.2 million (2021), against an average of -$3.0 million.
• Across the five-year window, Net Cash Flow surged 1434.03% in 2021 and slumped 2565.59% in 2025, its largest moves.
• Year by year, Net Cash Flow stood at -$1.1 million in 2021, then jumped by 165.19% to $691000.0 in 2022, then tumbled by 709.7% to -$4.2 million in 2023, then jumped by 172.51% to $3.1 million in 2024, then plunged by 1883.31% to -$54.5 million in 2025.
• Per Business Quant, the three latest NSPR Net Cash Flow figures stand at -$54.5 million (Q4 2025), $51.8 million (Q3 2025), and -$874000.0 (Q2 2025).